Actively Recruiting
Evaluating DHAARA-Fortified Human Milk Diets to Improve Lung Health in Extremely Preterm Infants A Randomized Trial to Reduce Bronchopulmonary Dysplasia
Led by University of Alabama at Birmingham · Updated on 2026-09-24
150
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying whether a diet enriched with docosahexaenoic acid DHA and arachidonic acid ARA given during the first 14 days of life can reduce breathing problems and improve lung function in extremely preterm infants born at 28 weeks gestation or earlier. This Phase II randomized trial compares the effects of a DHAARA-fortified human milk diet to a standard fortified human milk diet. The study aims to prevent bronchopulmonary dysplasia, a lung condition common in these infants. Participants will be randomly assigned to one of two groups. The intervention group will receive a standard fortified human milk diet plus DHAARA supplements at either a low or high dose for the first two weeks after birth. The control group will receive the standard fortified human milk diet without added supplements during the same period. This parallel-group design is masked so that participants and staff do not know the group assignments. During the study, infants will be monitored for up to 120 days. Researchers will assess the severity of respiratory issues and measure lung mechanics using non-invasive impulse oscillometry between days 40 and 120. They will also track bronchopulmonary dysplasia during this time. The trial includes detailed assessments and safety monitoring to understand how early nutritional delivery affects lung health in extremely preterm babies.
CONDITIONS
Brief Title
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
Research Team
A
Ariel A. Salas, MD, MSPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here